Medincell applauds teva and royalty pharma collaboration to further accelerate olanzapine lai program (codename: mdc-tjk or tev-‘749)

Montpellier, france--(business wire)--regulatory news: medincell (paris:medcl): in a joint press release announcing the financing agreement: richard francis, president and ceo of teva said: “since launching teva's pivot to growth strategy in may 2023, we have been working on novel and expedited ways to both continue to invest in our robust innovative pipeline while supporting the growth of our in-line businesses. we are excited to collaborate with royalty pharma, a major funder of innovation wi.
TEVA Ratings Summary
TEVA Quant Ranking